LYNZ PARKER: Open Payments
NPI 1992420053 · PORT CHARLOTTE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$299 in 16 payments from 7 companies in 2025. Trend: 2023 $923 · 2024 $288 · 2025 $299
Food & beverage: $299
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $157 |
| Astellas Pharma US Inc | 2 | $44 |
| Novo Nordisk Inc | 2 | $32 |
| Boston Scientific Corporation | 1 | $20 |
| Lilly USA, LLC | 1 | $17 |
| Dexcom, Inc. | 1 | $15 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
Products named: QULIPTA, Veozah, Rybelsus, Axonics, MOUNJARO, Dexcom G6 Transmitter, GEMTESA.
Industry payments across FL — which companies pay providers there.
